Literature DB >> 15231813

Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium.

Pauline Yoong1, Raymond Schuch, Daniel Nelson, Vincent A Fischetti.   

Abstract

Enterococcus faecalis and Enterococcus faecium infections are increasingly difficult to treat due to high levels of resistance to antibiotics. PlyV12, a bacteriophage lytic enzyme, was isolated and shown to effectively kill both E. faecalis and E. faecium (including vancomycin-resistant strains), as well as other human pathogens. We propose its development and use as an alternative therapeutic tool. Copyright 2004 American Society for Microbiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231813      PMCID: PMC438584          DOI: 10.1128/JB.186.14.4808-4812.2004

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  20 in total

1.  Phages will out: strategies of host cell lysis.

Authors:  I Young; I Wang; W D Roof
Journal:  Trends Microbiol       Date:  2000-03       Impact factor: 17.079

2.  Phage antibacterials make a comeback.

Authors:  V A Fischetti
Journal:  Nat Biotechnol       Date:  2001-08       Impact factor: 54.908

Review 3.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 4.  Novel method to control pathogenic bacteria on human mucous membranes.

Authors:  Vincent A Fischetti
Journal:  Ann N Y Acad Sci       Date:  2003-04       Impact factor: 5.691

5.  The lytic enzyme of the pneumococcal phage Dp-1: a chimeric lysin of intergeneric origin.

Authors:  M M Sheehan; J L García; R López; P García
Journal:  Mol Microbiol       Date:  1997-08       Impact factor: 3.501

6.  Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase.

Authors:  J M Loeffler; D Nelson; V A Fischetti
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

7.  Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme.

Authors:  D Nelson; L Loomis; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

Review 8.  Biological roles of two new murein hydrolases of Streptococcus pneumoniae representing examples of module shuffling.

Authors:  R López; M P González; E García; J L García; P García
Journal:  Res Microbiol       Date:  2000 Jul-Aug       Impact factor: 3.992

9.  C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates.

Authors:  Martin J Loessner; Karl Kramer; Frank Ebel; Siegfried Scherer
Journal:  Mol Microbiol       Date:  2002-04       Impact factor: 3.501

10.  A bacteriolytic agent that detects and kills Bacillus anthracis.

Authors:  Raymond Schuch; Daniel Nelson; Vincent A Fischetti
Journal:  Nature       Date:  2002-08-22       Impact factor: 49.962

View more
  65 in total

Review 1.  Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens.

Authors:  Vincent A Fischetti
Journal:  Int J Med Microbiol       Date:  2010-05-10       Impact factor: 3.473

2.  The structure of a family GH25 lysozyme from Aspergillus fumigatus.

Authors:  Justyna E Korczynska; Steffen Danielsen; Ulrika Schagerlöf; Johan P Turkenburg; Gideon J Davies; Keith S Wilson; Edward J Taylor
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-08-21

3.  The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus.

Authors:  S O'Flaherty; A Coffey; W Meaney; G F Fitzgerald; R P Ross
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

4.  Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme.

Authors:  Qi Cheng; Daniel Nelson; Shiwei Zhu; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins.

Authors:  Lieh Yoon Low; Chen Yang; Marta Perego; Andrei Osterman; Robert Liddington
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

Review 6.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

7.  Characterization of LytA-like N-acetylmuramoyl-L-alanine amidases from two new Streptococcus mitis bacteriophages provides insights into the properties of the major pneumococcal autolysin.

Authors:  Patricia Romero; Rubens López; Ernesto García
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

8.  Vibrio vulnificus bacteriophage SSP002 as a possible biocontrol agent.

Authors:  Hyun Sung Lee; Slae Choi; Hakdong Shin; Ju-Hoon Lee; Sang Ho Choi
Journal:  Appl Environ Microbiol       Date:  2013-11-08       Impact factor: 4.792

9.  The effectiveness of extended binding affinity of prophage lysin PlyARI against Streptococcus suis infection.

Authors:  Yuyi Xiao; Rong Chen; Min Li; Zitai Qi; Yanfei Yu; Zihao Pan; Huochun Yao; Zhixin Feng; Wei Zhang
Journal:  Arch Microbiol       Date:  2021-08-02       Impact factor: 2.552

10.  Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.

Authors:  Anu Daniel; Chad Euler; Mattias Collin; Peter Chahales; Kenneth J Gorelick; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.